Formosa Laboratories, Inc. (TPE:4746)

Market Cap	6.53B -4.4%
Revenue (ttm)	4.85B +2.5%
Net Income	441.11M +180.5%
EPS	3.64 +180.0%
Shares Out	120.26M
PE Ratio	14.92
Forward PE	n/a
Dividend	3.00 (5.52%)
Ex-Dividend Date	Aug 21, 2025

Volume	917,909
Average Volume	1,057,285
Open	55.30
Previous Close	54.80
Day's Range	53.80 - 55.50
52-Week Range	50.00 - 72.50
Beta	0.64
RSI	50.52
Earnings Date	May 15, 2026

About Formosa Laboratories

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 280
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4746

Financial Performance

In 2025, Formosa Laboratories's revenue was 4.85 billion, an increase of 2.54% compared to the previous year's 4.73 billion. Earnings were 441.11 million, an increase of 180.48%.